VTVT logo

VTv Therapeutics (VTVT) Return On Equity

Annual ROE

82.05%
+264.04%+145.08%

December 31, 2023


Summary


Performance

VTVT ROE Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherVTVTprofitabilitymetrics:

Quarterly ROE

-265.31%
-903.72%-141.56%

September 30, 2024


Summary


Performance

VTVT Quarterly ROE Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherVTVTprofitabilitymetrics:

ROE Formula

ROE =  Net Income
Shareholders Equity
✕ 100%

VTVT ROE Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+145.1%-141.6%
3 y3 years+673.3%+58.7%
5 y5 years+759.2%-1037.5%

VTVT ROE Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+145.1%-141.6%+58.7%
5 y5-yearat high+145.1%-141.6%+58.7%
alltimeall timeat high+130.4%-141.6%+58.7%

VTv Therapeutics ROE History

DateAnnualQuarterly
Sep 2024
-
-265.31%(-141.6%)
Jun 2024
-
638.41%(+321.1%)
Mar 2024
-
151.59%(+76.6%)
Dec 2023
82.05%(-145.1%)
85.82%(-19.8%)
Sep 2023
-
106.99%(-116.6%)
Jun 2023
-
-643.00%(+112.7%)
Mar 2023
-
-302.30%(+33.6%)
Dec 2022
-181.99%(+33.2%)
-226.19%(+25.6%)
Sep 2022
-
-180.15%(+26.7%)
Jun 2022
-
-142.23%(+14.3%)
Mar 2022
-
-124.43%(+16.5%)
Dec 2021
-136.60%(-1387.5%)
-106.77%(+76.8%)
Sep 2021
-
-60.40%(-75.6%)
Jun 2021
-
-247.90%(-2089.6%)
Mar 2021
-
12.46%(-3.6%)
Dec 2020
10.61%(-60.1%)
12.93%(-46.6%)
Sep 2020
-
24.21%(-14.5%)
Jun 2020
-
28.30%(-5.8%)
Mar 2020
-
30.04%(+17.3%)
Dec 2019
26.61%
25.60%(+56.2%)
DateAnnualQuarterly
Sep 2019
-
16.39%(+38.8%)
Jun 2019
-
11.81%(+6.3%)
Mar 2019
-
11.11%(+22.0%)
Dec 2018
9.55%(-103.5%)
9.11%(-15.0%)
Sep 2018
-
10.72%(-2.7%)
Jun 2018
-
11.02%(+0.5%)
Mar 2018
-
10.97%(-104.1%)
Dec 2017
-269.90%(+850.0%)
-267.05%(+215.2%)
Sep 2017
-
-84.72%(+63.0%)
Jun 2017
-
-51.96%(+37.4%)
Mar 2017
-
-37.82%(+32.5%)
Dec 2016
-28.41%(-88.2%)
-28.55%(+28.8%)
Sep 2016
-
-22.17%(-36.2%)
Jun 2016
-
-34.77%(-68.7%)
Mar 2016
-
-111.24%(-427.3%)
Dec 2015
-240.78%(-505.0%)
33.99%(-18.7%)
Sep 2015
-
41.83%(-12.5%)
Jun 2015
-
47.80%(+1.8%)
Mar 2015
-
46.94%(-21.0%)
Dec 2014
59.45%(+274.6%)
59.45%
Dec 2013
15.87%
-

FAQ

  • What is vTv Therapeutics annual return on equity?
  • What is the all time high annual ROE for vTv Therapeutics?
  • What is vTv Therapeutics annual ROE year-on-year change?
  • What is vTv Therapeutics quarterly return on equity?
  • What is the all time high quarterly ROE for vTv Therapeutics?
  • What is vTv Therapeutics quarterly ROE year-on-year change?

What is vTv Therapeutics annual return on equity?

The current annual ROE of VTVT is 82.05%

What is the all time high annual ROE for vTv Therapeutics?

vTv Therapeutics all-time high annual return on equity is 82.05%

What is vTv Therapeutics annual ROE year-on-year change?

Over the past year, VTVT annual return on equity has changed by +264.04% (+145.08%)

What is vTv Therapeutics quarterly return on equity?

The current quarterly ROE of VTVT is -265.31%

What is the all time high quarterly ROE for vTv Therapeutics?

vTv Therapeutics all-time high quarterly return on equity is 638.41%

What is vTv Therapeutics quarterly ROE year-on-year change?

Over the past year, VTVT quarterly return on equity has changed by -903.72% (-141.56%)